Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...
As of March 10 at 3:53:23 PM EDT. Market Open.
$ 430.00 1.33 0.31% ...
Durvalumab with etoposide and either carboplatin or cisplatin for untreated extensive-stage small-cell lung cancer TA1041 19 February 2025 19 February 2025 Selpercatinib for previously treated RET ...
Current price $440.03 52-week high $542.75 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback